Jaguar Health Statistics
Total Valuation
Jaguar Health has a market cap or net worth of $2.62 million. The enterprise value is $23.62 million.
Important Dates
The next estimated earnings date is Tuesday, May 13, 2025, before market open.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Jaguar Health has 523,531 shares outstanding.
| Current Share Class | 523,531 |
| Shares Outstanding | 523,531 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +298.83% |
| Owned by Insiders (%) | 12.54% |
| Owned by Institutions (%) | 2.12% |
| Float | 426,054 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.09 |
| Forward PS | 0.18 |
| PB Ratio | 0.15 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.25 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.84, with a Debt / Equity ratio of 2.20.
| Current Ratio | 1.84 |
| Quick Ratio | 0.73 |
| Debt / Equity | 2.20 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -50.70 |
Financial Efficiency
Return on equity (ROE) is -450.92% and return on invested capital (ROIC) is -43.00%.
| Return on Equity (ROE) | -450.92% |
| Return on Assets (ROA) | -35.94% |
| Return on Invested Capital (ROIC) | -43.00% |
| Return on Capital Employed (ROCE) | -77.37% |
| Revenue Per Employee | $213,878 |
| Profits Per Employee | -$770,245 |
| Employee Count | 49 |
| Asset Turnover | 0.20 |
| Inventory Turnover | 0.23 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -95.43% in the last 52 weeks. The beta is 0.81, so Jaguar Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.81 |
| 52-Week Price Change | -95.43% |
| 50-Day Moving Average | 16.49 |
| 200-Day Moving Average | 34.64 |
| Relative Strength Index (RSI) | 21.11 |
| Average Volume (20 Days) | 37,124 |
Short Selling Information
| Short Interest | 891,219 |
| Short Previous Month | 953,074 |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.14 |
Income Statement
In the last 12 months, Jaguar Health had revenue of $10.48 million and -$37.74 million in losses. Loss per share was -$205.60.
| Revenue | 10.48M |
| Gross Profit | 8.40M |
| Operating Income | -29.86M |
| Pretax Income | -38.32M |
| Net Income | -37.74M |
| EBITDA | -27.94M |
| EBIT | -29.86M |
| Loss Per Share | -$205.60 |
Full Income StatementBalance Sheet
The company has $13.27 million in cash and $34.27 million in debt, giving a net cash position of -$21.00 million or -$40.11 per share.
| Cash & Cash Equivalents | 13.27M |
| Total Debt | 34.27M |
| Net Cash | -21.00M |
| Net Cash Per Share | -$40.11 |
| Equity (Book Value) | 15.58M |
| Book Value Per Share | 32.66 |
| Working Capital | 16.77M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$29.01 million and capital expenditures -$16,000, giving a free cash flow of -$29.03 million.
| Operating Cash Flow | -29.01M |
| Capital Expenditures | -16,000 |
| Free Cash Flow | -29.03M |
| FCF Per Share | -$55.44 |
Full Cash Flow StatementMargins
| Gross Margin | 80.10% |
| Operating Margin | -284.92% |
| Pretax Margin | -365.71% |
| Profit Margin | n/a |
| EBITDA Margin | -266.56% |
| EBIT Margin | -284.92% |
| FCF Margin | n/a |